OTC Markets OTCQB - Delayed Quote USD

Onco-Innovations Limited (ONNVF)

0.1783 0.0000 (0.00%)

At close: October 30 at 5:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

ACCESS Newswire 1mo ago

AIRX.CN

ONCO.NE

RDWCF
Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

ACCESS Newswire 1mo ago

AIRX.CN

ONCO.NE

W1H.F
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd.

GlobeNewswire 1mo ago

ONCO.NE

ONNVF
0.00%
Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

ACCESS Newswire 3mo ago

ONCO.NE

CBOE

ONCO
Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing

ACCESS Newswire 4mo ago

ONCO.NE

CBOE

W1H.F
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

ACCESS Newswire 4mo ago

ONCO.NE

CBOE

ONNVF
0.00%
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes

GlobeNewswire 4mo ago

ONCO.NE

CBOE

ONNVF
0.00%
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

ACCESS Newswire 4mo ago

ONCO.NE

CBOE

W1H.F
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

ACCESS Newswire 4mo ago

ONCO

W1H

ONNVF
0.00%
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

ACCESS Newswire 4mo ago

ONCO.NE

CBOE

ONNVF
0.00%
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

ACCESS Newswire 5mo ago

ONCO.NE

CBOE

GSK.L
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

ACCESS Newswire 6mo ago

ONCO.NE

CBOE

ONCO

Performance Overview

Return	ONNVF	MSCI WORLD (^990100-USD-STRD)
YTD	-51.24%	+9.32%
1-Year	-51.24%	+10.20%
3-Year	-51.24%	+67.94%

U.S. markets closed

Onco-Innovations Limited (ONNVF)

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Islam Mohamed, Chief Medical Officer of Onco-Innovations Ltd.

Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development